Thyrocare's promoter, Docon Technologies, has released a pledge on 1.75 crore equity shares of the company.

Previously, Docon had pledged its entire 60.92% stake as security for Non-Convertible Debentures (NCDs) issued by its holding company, API Holdings.

This move reduces Docon's encumbered (pledged) shareholding in Thyrocare from 60.92% to 49.93%. This is a positive development for investors, as it indicates a reduction in the financial obligations tied to the promoter's shares.

The outstanding NCDs from API Holdings now stand at INR 1,050 Cr.